Ming-Da Wang
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in
- Hepatology 86
- Hepatocellular Carcinoma Treatment and Prognosis 85
- Oncology 7
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Feng Shen (42 shared papers)Tian Yang (48 shared papers)Han Wu (30 shared papers)Lei Liang (22 shared papers)Hao Xing (24 shared papers)Wan Yee Lau (31 shared papers)Timothy Michael Pawlik (29 shared papers)Mengchao Wu (17 shared papers)
- Journals
- Annals of Surgical Oncology (8 papers)European Journal of Surgical Oncology (8 papers)HPB (8 papers)Journal of Gastrointestinal Surgery (5 papers)The American Journal of Surgery (4 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Ming-Da Wang
108 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 94
- Hepatology 1.1k
- Cancer Research 146
- Drug Discovery 3
- Molecular Medicine 51
- Oncology 141
Countries citing papers authored by Ming-Da Wang
This map shows the geographic impact of Ming-Da Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Da Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Da Wang more than expected).
Fields of papers citing papers by Ming-Da Wang
This network shows the impact of papers produced by Ming-Da Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Da Wang. The network helps show where Ming-Da Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming-Da Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 98 | |
| 2 | 2022 | 76 | |
| 3 | 2016 | 73 | |
| 4 | 2019 | 66 | |
| 5 | 2022 | 66 | |
| 6 | 2019 | 64 | |
| 7 | 2018 | 52 | |
| 8 | 2017 | 51 | |
| 9 | 2021 | 51 | |
| 10 | 2016 | 50 | |
| 11 | 2022 | 49 | |
| 12 | 2021 | 47 | |
| 13 | 2018 | 45 | |
| 14 | 2019 | 42 | |
| 15 | 2019 | 41 | |
| 16 | 2018 | 35 | |
| 17 | 2021 | 35 | |
| 18 | 2024 | 34 | |
| 19 | 2021 | 31 | |
| 20 | 2025 | 30 |
About Ming-Da Wang
Ming-Da Wang is a scholar working on Hepatology, Oncology, Cancer Research, Epidemiology and Geriatrics and Gerontology, having authored 119 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (85 papers), Nanoplatforms for cancer theranostics (4 papers), Hepatitis B Virus Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Frailty in Older Adults (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Epigenetics and DNA Methylation (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Hepatology (1.1k citations), Cancer Research (146 citations), Drug Discovery (3 citations), Molecular Medicine (51 citations) and Oncology (141 citations). Ming-Da Wang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Feng Shen, Tian Yang, Han Wu, Lei Liang, Hao Xing, Wan Yee Lau, Timothy Michael Pawlik, Mengchao Wu, Chao Li and Li‐Yang Sun. Their work appears in journals such as Annals of Surgical Oncology, European Journal of Surgical Oncology, HPB, Journal of Gastrointestinal Surgery and The American Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.